THOUSAND OAKS, Calif. (AP) — THOUSAND OAKS, Calif. (AP) — Atara Biotherapeutics Inc. (ATRA) on Monday reported a loss of $74.8 million in its first quarter.
On a per-share basis, the Thousand Oaks, California-based company said it had a loss of 72 cents.
The results fell short of Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 40 cents per share.
The drug developer posted revenue of $1.2 million in the period, also missing Street forecasts. Three analysts surveyed by Zacks expected $37.7 million.
In the final minutes of trading on Monday, the company’s shares hit $2.98. A year ago, they were trading at $6.92.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ATRA at https://www.zacks.com/ap/ATRA
Copyright © 2023 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.